Results 261 to 270 of about 135,172 (298)

Tixagevimab–Cilgavimab: COVID-19 Pre-Exposure Prophylaxis

Clinical Journal of Oncology Nursing, 2022
Tixagevimab-cilgavimab is the only nonvaccine drug currently authorized in the United States for the prevention of COVID-19 infection in individuals who are moderately to severely immunocompromised or unable to receive COVI.
openaire   +2 more sources

Oral pre-exposure prophylaxis for HIV prevention

Trends in Pharmacological Sciences, 2010
In the absence of an effective vaccine, HIV continues to spread worldwide, emphasizing the need for new biomedical interventions to limit its transmission. Appreciation of the challenges that HIV has to face to initiate an infection mucosally has spurred interest in evaluating the use of antiretroviral drugs to prevent infection.
J Gerardo, García-Lerma, Lynn, Paxton, Peter H, Kilmarx, Walid, Heneine   +3 more
openaire   +2 more sources

[Focus on pre-exposure prophylaxis].

Revue de l'infirmiere, 2013
Pre-exposure prophylaxis currently has no market authorisation in France, but is still evaluated. This article presents an additional tool for risk reduction, currently the subject of studies.
Emma, Torres, Jean-Luc, Meynard
openaire   +1 more source

Online Prescriptions to HIV Pre-Exposure Prophylaxis and Pre-Exposure Prophylaxis Uptake

AIDS Patient Care and STDs, 2020
Lexie, Wille, Mike C, Parent
openaire   +2 more sources

Pre-exposure prophylaxis in the perinatal period

The Lancet HIV
Women in sub-Saharan Africa are at high risk for HIV acquisition during pregnancy and postpartum periods, which puts the health of perinatal people at risk, but also contributes to new paediatric infections. Pre-exposure prophylaxis (PrEP) to prevent HIV is a highly effective intervention to prevent HIV acquisition.
Sheree, Schwartz, Friday, Saidi
openaire   +2 more sources

Prescribing pre-exposure prophylaxis therapy

Journal of Prescribing Practice
Deborah Robertson provides an overview of recently published articles that may be of interest to non-medical prescribers. Should you wish to look at any of the papers in more detail, a full reference is provided
openaire   +1 more source

Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide

Cell, 2022
Jing Xue, Yuanmei Zhu, Jingjing Zhang
exaly  

Pre-Exposure Prophylaxis for HIV

American Journal of Preventive Medicine, 2013
James W. Curran, Richard A. Crosby
openaire   +2 more sources

RABIES Pre-Exposure prophylaxis

2022
openaire   +1 more source

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Lancet, The, 2020
jean-michel Molina, Peter L Anderson, Christian Callebaut   +2 more
exaly